AstraZeneca PLC
-
Business
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024…
Read More » -
Health News
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk…
Read More » -
Health News
Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock
[ad_1] Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking…
Read More » -
Health News
Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly
[ad_1] Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news…
Read More » -
Health News
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
[ad_1] A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany,…
Read More » -
Health News
Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom. Here’s why, analyst says
[ad_1] Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? For Deutsche Bank analyst James Shin,…
Read More » -
Health News
Drugmakers opt in to Medicare drug price negotiations – here’s what happens next
[ad_1] A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah,…
Read More » -
Business
Federal judge declines to block Medicare price negotiations
[ad_1] A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah,…
Read More » -
Health News
AstraZeneca, Bristol Myers Squibb to participate in Medicare drug price negotiations
[ad_1] In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29,…
Read More » -
Pics News
Jefferies upgrades this pharma stock, citing overlooked ‘blockbuster’ drug opportunities
[ad_1] AstraZeneca has a robust pipeline of therapies beyond oncology that investors shouldn’t ignore, according to Jefferies. Analyst Peter Welford…
Read More »